Drug Type Therapeutic radiopharmaceuticals |
Synonyms ITM-11+ITM-80 |
Target |
Action antagonists |
Mechanism SSTR antagonists(Somatostatin receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroendocrine Carcinoma | Preclinical | Germany | 07 Jun 2024 |